Teleflex Stock Forecast, Price & News

+1.32 (+0.31 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: $432.56
50-Day Range
MA: $411.94
52-Week Range
Now: $432.56
Volume228,813 shs
Average Volume202,868 shs
Market Capitalization$20.22 billion
P/E Ratio55.67
Dividend Yield0.32%
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Teleflex logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
Year Founded1943



Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$17.46 per share
Book Value$64.35 per share


Net Income$461.47 million


Market Cap$20.22 billion
Next Earnings Date4/29/2021 (Confirmed)


Teleflex (NYSE:TFX) Sets New 52-Week High at $435.00
April 15, 2021 |  americanbankingnews.com
Is TFX Stock A Buy?
April 14, 2021 |  finance.yahoo.com
What Teleflex $TFX is Telling us About its Future
March 22, 2021 |  marketwatch.com
See More Headlines


Overall MarketRank

1.79 out of 5 stars

Medical Sector

155th out of 2,021 stocks

Surgical & Medical Instruments Industry

19th out of 169 stocks

Analyst Opinion: 1.6Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
+1.32 (+0.31 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Teleflex (NYSE:TFX) Frequently Asked Questions

Is Teleflex a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex
or view top-rated stocks.

What stocks does MarketBeat like better than Teleflex?

Wall Street analysts have given Teleflex a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teleflex wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Teleflex?

Teleflex saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 560,600 shares, a decrease of 17.8% from the March 15th total of 682,200 shares. Based on an average daily trading volume, of 202,400 shares, the days-to-cover ratio is presently 2.8 days.
View Teleflex's Short Interest

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Teleflex

How can I listen to Teleflex's earnings call?

Teleflex will be holding an earnings conference call on Thursday, April 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its earnings results on Thursday, February, 25th. The medical technology company reported $3.25 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $3.05 by $0.20. The medical technology company had revenue of $711.20 million for the quarter, compared to analyst estimates of $687.66 million. Teleflex had a trailing twelve-month return on equity of 16.33% and a net margin of 14.66%. Teleflex's quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.28 EPS.
View Teleflex's earnings history

How has Teleflex's stock price been impacted by Coronavirus?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TFX shares have increased by 26.4% and is now trading at $432.56.
View which stocks have been most impacted by COVID-19

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, February 25th. Stockholders of record on Friday, March 5th will be paid a dividend of $0.34 per share on Monday, March 15th. This represents a $1.36 annualized dividend and a yield of 0.31%. The ex-dividend date is Thursday, March 4th.
View Teleflex's dividend history

Is Teleflex a good dividend stock?

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.32%. Teleflex does not yet have a strock track record of dividend growth. The dividend payout ratio of Teleflex is 12.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 10.78% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY21 earnings guidance on Thursday, February, 25th. The company provided EPS guidance of $12.50-12.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.61. The company issued revenue guidance of $2.79-2.83 billion, compared to the consensus revenue estimate of $2.85 billion.

What price target have analysts set for TFX?

9 analysts have issued 12-month target prices for Teleflex's stock. Their forecasts range from $440.00 to $480.00. On average, they expect Teleflex's stock price to reach $453.44 in the next year. This suggests a possible upside of 4.8% from the stock's current price.
View analysts' price targets for Teleflex
or view top-rated stocks among Wall Street analysts.

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Chairman, Pres & CEO (Age 54, Pay $2.01M)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 59, Pay $1.08M)
  • Mr. Cameron P. Hicks, Corp. VP & Chief HR Officer (Age 56, Pay $543.81k)
  • Mr. James P. Winters, Corp. VP, Manufacturing and Supply Chain
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, VP & Chief Information Officer
  • Mr. Jacob P. Elguicze, Treasurer & VP of Investor Relations (Age 48)
  • Ms. Gwen Chapman, Chief Compliance Officer & Corp. VP (Age 46)
  • Mr. Daniel V. Logue, Corp. VP, Gen. Counsel & Sec. (Age 47)
  • Mr. James Ferguson, Pres & GM of Surgical - Latin America

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of institutional and retail investors. Top institutional shareholders include AMI Asset Management Corp (0.30%), Retirement Systems of Alabama (0.21%), Mountain Pacific Investment Advisers Inc. ID (0.16%), Scout Investments Inc. (0.10%), Buffington Mohr McNeal (0.05%) and Royal London Asset Management Ltd. (0.04%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Karen Boylan, Stephen K MD Klasko and Thomas E Powell.
View institutional ownership trends for Teleflex

Which major investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Chicago Capital LLC, Scout Investments Inc., Pacer Advisors Inc., Crossmark Global Holdings Inc., American Research & Management Co., Graves Light Private Wealth Management Inc., and First Hawaiian Bank. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, John Deren, and Stephen K MD Klasko.
View insider buying and selling activity for Teleflex
or view top insider-selling stocks.

Which major investors are buying Teleflex stock?

TFX stock was purchased by a variety of institutional investors in the last quarter, including AMI Asset Management Corp, Everence Capital Management Inc., Buffington Mohr McNeal, Royal London Asset Management Ltd., Bouvel Investment Partners LLC, Mountain Pacific Investment Advisers Inc. ID, and State of Alaska Department of Revenue.
View insider buying and selling activity for Teleflex
or or view top insider-buying stocks.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $432.56.

How much money does Teleflex make?

Teleflex has a market capitalization of $20.22 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis.

How many employees does Teleflex have?

Teleflex employs 14,000 workers across the globe.

When was Teleflex founded?

Teleflex was founded in 1943.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

Where are Teleflex's headquarters?

Teleflex is headquartered at 550 E SWEDESFORD RD, WAYNE PA, 19087.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.